tiprankstipranks
Trending News
More News >
Cedar. Co.,Ltd (JP:2435)
:2435
Japanese Market
Advertisement

Cedar. Co.,Ltd (2435) AI Stock Analysis

Compare
0 Followers

Top Page

JP:2435

Cedar. Co.,Ltd

(2435)

Rating:75Outperform
Price Target:
¥244.00
▲(9.91% Upside)
Cedar Co., Ltd scores well due to its strong valuation metrics, including a low P/E ratio and attractive dividend yield, which suggest it is undervalued. Technical indicators show positive momentum, supporting a potential upward trend. However, financial performance is moderated by high leverage and low equity ratio, which pose risks if not managed carefully.

Cedar. Co.,Ltd (2435) vs. iShares MSCI Japan ETF (EWJ)

Cedar. Co.,Ltd Business Overview & Revenue Model

Company DescriptionCedar Co., Ltd (2435) is a company that operates primarily in the healthcare sector, focusing on providing comprehensive nursing care services. The company is involved in offering a broad range of services, including home-visit nursing care, day care services, and residential care facilities. Cedar Co., Ltd aims to support the aging population by delivering quality care solutions that enhance the well-being and quality of life for elderly individuals.
How the Company Makes MoneyCedar Co., Ltd generates revenue through its diverse range of nursing care services tailored to meet the needs of the elderly population. The company earns money by providing home-visit nursing care, where caregivers visit clients' homes to offer medical and daily living support. Additionally, it operates day care centers and residential care facilities, where clients can receive assistance in a community setting. These services are typically funded through a combination of government subsidies, client fees, and private insurance payments. The company may also engage in partnerships with healthcare providers and local governments to expand its service offerings and improve accessibility to care, further contributing to its revenue streams.

Cedar. Co.,Ltd Financial Statement Overview

Summary
Cedar Co., Ltd demonstrates a positive growth trajectory with improving profitability and cash flow management. However, the high leverage and low equity ratio present potential risks that need careful management. The company is on a path to stronger financial health, but maintaining balance sheet stability will be crucial for sustained growth.
Income Statement
72
Positive
Cedar Co., Ltd has shown consistent revenue growth over the years, with a notable increase in gross profit margins, indicating improved operational efficiency. The net profit margin has also improved significantly from a negative position, reflecting better cost management and profitability. However, the EBIT and EBITDA margins, while positive, suggest room for further improvement in operational efficiency.
Balance Sheet
65
Positive
The company's debt-to-equity ratio is relatively high, indicating a leveraged position which could pose risks if not managed carefully. However, the return on equity has improved, showing better utilization of equity to generate profits. The equity ratio is low, suggesting reliance on debt financing, which could impact financial stability.
Cash Flow
68
Positive
Cedar Co., Ltd has shown positive free cash flow growth, indicating better cash management and operational efficiency. The operating cash flow to net income ratio is strong, suggesting effective conversion of earnings into cash. However, the free cash flow to net income ratio indicates potential areas for improvement in cash flow generation relative to net income.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue17.83B17.83B17.30B16.44B15.75B15.61B
Gross Profit2.29B2.29B2.21B1.59B1.55B2.07B
EBITDA1.80B1.66B1.45B831.00M728.00M1.47B
Net Income348.00M348.00M203.00M-276.00M-319.00M387.00M
Balance Sheet
Total Assets19.91B19.91B20.33B20.25B20.46B19.56B
Cash, Cash Equivalents and Short-Term Investments1.48B1.48B1.64B1.03B796.00M825.00M
Total Debt14.47B14.47B15.22B15.63B15.84B14.76B
Total Liabilities18.50B18.50B19.24B19.36B19.30B17.95B
Stockholders Equity1.39B1.39B1.08B889.00M1.16B1.61B
Cash Flow
Free Cash Flow0.00295.00M995.00M394.00M-984.00M-876.00M
Operating Cash Flow0.00777.00M1.47B797.00M513.00M1.14B
Investing Cash Flow0.00-142.00M-446.00M-358.00M-1.47B-2.06B
Financing Cash Flow0.00-791.00M-418.00M-207.00M928.00M881.00M

Cedar. Co.,Ltd Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price222.00
Price Trends
50DMA
220.24
Positive
100DMA
218.63
Positive
200DMA
219.85
Positive
Market Momentum
MACD
2.23
Positive
RSI
46.66
Neutral
STOCH
26.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2435, the sentiment is Neutral. The current price of 222 is below the 20-day moving average (MA) of 227.10, above the 50-day MA of 220.24, and above the 200-day MA of 219.85, indicating a neutral trend. The MACD of 2.23 indicates Positive momentum. The RSI at 46.66 is Neutral, neither overbought nor oversold. The STOCH value of 26.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:2435.

Cedar. Co.,Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥2.89B7.13
2.82%5.37%-9.33%
77
Outperform
¥3.07B9.55
2.47%-0.34%-21.06%
75
Outperform
¥3.20B10.96
2.62%4.76%134.83%
75
Outperform
¥2.56B5.44
4.39%2.45%205.19%
68
Neutral
¥6.42B2.92
3.01%0.92%1344.43%
63
Neutral
¥5.67B7.95
4.05%8.95%
51
Neutral
$7.93B-0.32-43.43%2.21%22.30%-1.88%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2435
Cedar. Co.,Ltd
222.00
24.14
12.20%
JP:2373
Care Twentyone Corporation
417.00
22.23
5.63%
JP:2425
Care Service Co., Ltd.
820.00
-0.91
-0.11%
JP:6059
Uchiyama Holdings Co., Ltd.
332.00
9.82
3.05%
JP:7129
Miahelsa Holdings Corporation
1,145.00
-9.51
-0.82%
JP:9220
FB CARE SERVICE CO.,LTD.
1,161.00
280.79
31.90%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 14, 2025